<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Melief, M.J.</title>
    <link>http://repub.eur.nl/res/aut/5717/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Myelin ingestion alters macrophage antigen-presenting function in vitro and in vivo (Article)</title>
      <link>http://repub.eur.nl/res/pub/26691/</link>
      <pubDate>2011-07-01T00:00:00Z</pubDate>
      <description>During MS, phagocytosing myelin-containing macrophages arise and lie in close proximity to T cells. To date, it has not been addressed whether these myelinladen macrophages have the capacity to present antigens to T cells and whether this contributes to inflammation in disease. We demonstrate that in vitro-generated human and mouse myelin-laden macrophages expressed MHC class I and II and costimulatory molecules and are thus well equipped for antigen presentation.uman myelin-laden macrophages exhibited normal endocytosis of particulate and soluble antigens. In addition, human myelin-laden macrophages elicited active T cell proliferation of nai{dotless}̈ve as well as memory T cells. Furthermore, mouse myelin-laden macrophages induced primary antigen-specific CD4+T cell proliferation in vivo but transiently diminished IFN-γ release. Functionally, MOG peptide-loaded myelin-laden mouse macrophages modestly but significantly reduced the severity of MOG peptide-induced EAE. These data show that myelin uptake results in the induction of a population of macrophages that retains antigen-presenting capacity and limits autoimmune-mediated disease. </description>
    </item> <item>
      <title>Myelin ingestion by macrophages promotes their motility and capacity to recruit myeloid cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/21099/</link>
      <pubDate>2010-08-01T00:00:00Z</pubDate>
      <description>Myelin-laden macrophages reside within the CNS, the CSF and in the CNS-draining lymph nodes during MS and EAE, suggesting migration of these macrophages between these compartments and interaction with other cells. Since chemokines and their receptors are pivotal for leukocyte trafficking, we addressed whether myelin ingestion affects chemotaxis of mouse macrophages in vitro. Myelin ingestion enhanced expression of CCR7 and CXCR3 on macrophages and migration towards CCL21 and CXCL10. Furthermore, myelin-laden macrophages released chemoattractants resulting in enhanced migration of myeloid cells in vitro. Our data demonstrate that myelin-laden macrophages have increased motility and suggest trafficking between anatomical compartments in vivo. © 2010 Elsevier B.V.</description>
    </item> <item>
      <title>Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis (Article)</title>
      <link>http://repub.eur.nl/res/pub/27323/</link>
      <pubDate>2010-05-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>A monoclonal antibody selection for immunohistochemical examination of lymphoid tissues from non-human primates (Article)</title>
      <link>http://repub.eur.nl/res/pub/25393/</link>
      <pubDate>2009-12-01T00:00:00Z</pubDate>
      <description>Non-human primates (NHPs) offer valuable animal models for basic research into human diseases and for the preclinical validation of new therapeutics. Detailed in situ examination of the involved cell types using immunohistochemistry is often hampered by the lack of cross-reactive antibodies (Abs). In the current study, we have tested a large panel of monoclonal antibodies raised against human leukocyte differentiation and activation markers for cross-reactivity on cryosections of lymphoid tissue from six NHP species. In total, we have tested 130 Abs against 69 antigens expressed in tissues from one great ape species (chimpanzee/Pan troglodytes), two Old World species (rhesus macaque/Macaca mulatta and cynomolgus macaque/Macaca fascicularis), and three New World species (common marmoset/Callithrix jacchus, cotton-top tamarin/Saguinus oedipus, and owl monkey/Aotus triviogatus). We have found a large panel of cross-reactive Abs: 93 of 102 (91%) in chimpanzee, 97 of 125 (78%) in rhesus macaque, 70 of 109 (64%) in cynomolgus macaque, 69 of 116 (60%) in common marmoset, 40 of 81 (49%) in cotton-top tamarin, and 35 of 80 (44%) in owl monkey. The availability of a reliable panel of cross-reactive markers is important to gaining further insight into immunological processes in disease-affected tissues from NHP species. </description>
    </item> <item>
      <title>Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis (Article)</title>
      <link>http://repub.eur.nl/res/pub/24107/</link>
      <pubDate>2009-03-01T00:00:00Z</pubDate>
      <description>Despite lack of classical lymphatic vessels in the central nervous system (CNS), cells and antigens do reach the CNS-draining lymph nodes. These lymph nodes are specialized to mediate mucosal immune tolerance, but can also generate T- and B-cell immunity. Their role in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) therefore remains elusive. We hypothesized that drainage of CNS antigens to the CNS-draining lymph nodes is vital for the recurrent episodes of CNS inflammation. To test this, we surgically removed the superficial cervical lymph nodes, deep cervical lymph nodes, and the lumbar lymph nodes prior to disease induction in three mouse EAE models, representing acute, chronic, and chronic-relapsing EAE. Excision of the CNS-draining lymph nodes in chronic-relapsing EAE reduced and delayed the relapse burden and EAE pathology within the spinal cord, which suggests initiation of CNS antigen-specific immune responses within the CNS-draining lymph nodes. Indeed, superficial cervical lymph nodes from EAE-affected mice demonstrated proliferation against the immunizing peptide, and the deep cervical lymph nodes, lumbar lymph nodes, and spleen demonstrated additional proliferation against other myelin antigen epitopes. This indicates that intermolecular epitope spreading occurs and that CNS antigen-specific immune responses are differentially generated within the different CNS-draining lymphoid organs. Proliferation of splenocytes from lymphadenectomized and sham-operated mice against the immunizing peptide was similar. These data suggest a role for CNS-draining lymph nodes in the induction of detrimental immune responses in EAE relapses, and conclusively demonstrate that the tolerance-inducing capability of cervical lymph nodes is not involved in EAE. Copyright </description>
    </item> <item>
      <title>Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE (Article)</title>
      <link>http://repub.eur.nl/res/pub/24143/</link>
      <pubDate>2009-03-01T00:00:00Z</pubDate>
      <description>Drainage of central nervous system (CNS) antigens to the brain-draining cervical lymph nodes (CLN) is likely crucial in the initiation and control of autoimmune responses during multiple sclerosis (MS). We demonstrate neuronal antigens within CLN of MS patients. In monkeys and mice with experimental autoimmune encephalomyelitis (EAE) and in mouse models with non-inflammatory CNS damage, the type and extent of CNS damage was associated with the frequencies of CNS antigens within the cervical lymph nodes. In addition, CNS antigens drained to the spinal-cord-draining lumbar lymph nodes. In human MS CLN, neuronal antigens were present in pro-inflammatory antigen-presenting cells (APC), whereas the majority of myelin-containing cells were anti-inflammatory. This may reflect a different origin of the cells or different drainage mechanisms. Indeed, neuronal antigen-containing cells in human CLN did not express the lymph node homing receptor CCR7, whereas myelin antigen-containing cells in situ and in vitro did. Nevertheless, CLN from EAE-affected CCR7-deficient mice contained equal amounts of myelin and neuronal antigens as wild-type mice. We conclude that the type and frequencies of CNS antigens within the CLN are determined by the type and extent of CNS damage. Furthermore, the presence of myelin and neuronal antigens in functionally distinct APC populations within MS CLN suggests that differential immune responses can be evoked. </description>
    </item> <item>
      <title>Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/10370/</link>
      <pubDate>2005-01-01T00:00:00Z</pubDate>
      <description>Upon stimulation by microbial products through TLR, dendritic cells (DC) acquire the capacity to prime naive T cells and to initiate a proinflammatory immune response. Recently, we have shown that APC within the CNS of multiple sclerosis (MS) patients contain peptidoglycan (PGN), a major cell wall component of Gram-positive bacteria, which signals through TLR and NOD. In this study, we report that Staphylococcus aureus PGN as a single component can support the induction of experimental autoimmune encephalomyelitis (EAE) in mice, an animal model for MS. Mice immunized with an encephalitogenic myelin oligodendrocyte glycoprotein peptide in IFA did not develop EAE. In contrast, addition of PGN to the emulsion was sufficient for priming of autoreactive Th1 cells and development of EAE.
      In vitro studies demonstrate that PGN stimulates DC-mediated processes,
      reflected by increased Ag uptake, DC maturation, Th1 cell expansion,
      activation, and proinflammatory cytokine production. These data indicate
      that PGN-mediated interactions result in proinflammatory stimulation of
      Ag-specific effector functions, which are important in the development of
      EAE. These PGN-mediated processes may occur both within the peripheral
      lymph nodes as well as in the CNS and likely involve recognition by TLR on
      DC. Thus, PGN may provide a physiological trigger of DC maturation, and in
      this way disrupt the normal tolerance to self Ag. As such, PGN signaling
      pathways may serve as novel targets for the treatment of MS.</description>
    </item> <item>
      <title>Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects (Article)</title>
      <link>http://repub.eur.nl/res/pub/9627/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVES: Peptidoglycan (PG), a component of Gram-positive bacteria, may
          be involved in rheumatoid arthritis (RA) because of its ability to induce
          production of proinflammatory cytokines, to induce arthritis in rodents,
          and its presence in antigen-presenting cells in RA joints. METHODS: In the
          present study, physiologically relevant PG was able to induce T-cell
          proliferation in peripheral blood and synovial fluid samples of RA
          patients, but the magnitude of the response did not differ from that of
          cells from healthy subjects. In addition, production of cytokines
          associated with RA (interleukins (IL)-1beta, IL-6, IL-8, IL-10, IL-12 and
          tumour necrosis factor alpha) and of the matrix metalloproteinase,
          gelatinase B (MMP-9), was induced in blood and synovial fluid cultures of
          RA patients. CONCLUSION: The fact that PG, which can be found in synovial
          tissues of RA patients is able to induce the production of inflammatory
          mediators supports the hypothesis that PG plays a role in the pathogenesis
          of RA by influencing the inflammatory microenvironment of the joint.</description>
    </item> <item>
      <title>Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis (Article)</title>
      <link>http://repub.eur.nl/res/pub/9687/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Multiple sclerosis is believed to result from a CD4+ T-cell response
      against myelin antigens. Peptidoglycan, a major component of the
      Gram-positive bacterial cell wall, is a functional lipopolysaccharide
      analogue with potent proinflammatory properties and is conceivably a
      mediator of sterile inflammation. Here we demonstrate that peptidoglycan
      is present within antigen-presenting cells in the brain of multiple
      sclerosis patients. These cells have macrophage and dendritic cell
      characteristics, and are immunocompetent as evidenced by co-expression of
      inflammatory cytokines and co-stimulatory molecules. In addition,
      intrathecal plasma cells specific for peptidoglycan are present in
      multiple sclerosis brain tissue, and antibodies binding peptidoglycan are
      present in CSF during active disease. Peptidoglycan may thus contribute to
      T- and B-cell activity during brain inflammation without a requirement for
      local bacterial replication.</description>
    </item> <item>
      <title>Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis (Article)</title>
      <link>http://repub.eur.nl/res/pub/9070/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Somatostatin is a neuropeptide that is widely distributed throughout the
          body. It acts as a neurohormone and a neurotransmitter and may also have
          an immunomodulatory role. The genes for five subtypes of somatostatin
          receptors (sst) have been cloned, suggesting that the diverse effects of
          the peptide might be mediated by different receptors. We are interested in
          studying the role of sst ininflammation, using an animal model. Because of
          the up-regulation of sst expression in inflamed joints in human rheumatoid
          arthritis, we chose rat adjuvant arthritis as an experimental model. In
          order to determine which of the sst subtypes might be important in immune
          modulation, subtype expression in leukocytes isolated from different
          lymphoid tissues of the rat was studied. Also, the expression levels of
          the most abundantly expressed sst mRNAs in leukocytes from spleen and
          blood were compared in rats with adjuvantarthritis and controls, using a
          semi-quantitative approach. Furthermore, the effect of systemic
          administration of a long-acting somatostatin analogue, octreotide, which
          binds selectively to sst subtypes 2 and 5 (sst2 and sst5), on the
          incidence and the severity of rat adjuvant arthritis, was studied. The
          main sst expressed in cells of the rat immune system, both resting and
          activated, were found to be sst3 and sst4. This contrasts with the human
          and murine situations, in which sst2 appears to be the main subtype
          expressed in the immune system. No quantitative differences in sst subtype
          mRNA levels in leukocytes from spleen and blood were found between rats
          with adjuvant arthritis and controls. Finally, no effect of systemic
          administration of octreotide on either the incidence or severity of
          adjuvant arthritis in Lewis rats was found. As octreotide binds
          selectively to sst2 and sst5, the absence of an immunomodulatory effect of
          this analogue in rat adjuvant arthritis corroborates our finding that
          these sst subtypes are not expressed in cells of the rat immune system. In
          conclusion, cells of the rat immune system appear to express a spectrum of
          sst (sst3 and sst4) different from that found in human granulomatous and
          autoimmune disease (mainly sst2). Therefore, the rat adjuvant arthritis
          model appears to be suitable only for studying the immunomodulatory
          effects of somatostatin analogues which have a high affinity for sst3 and
          sst4, but not for studying the immunomodulatory effects of octreotide,
          which has a high affinity only for sst2 and sst5.</description>
    </item> <item>
      <title>Detection of muramic acid in a carbohydrate fraction of human spleen (Article)</title>
      <link>http://repub.eur.nl/res/pub/8556/</link>
      <pubDate>1995-01-01T00:00:00Z</pubDate>
      <description>In previous studies, we showed that peptidoglycan polysaccharides from
          anaerobic bacteria normally present in the human gut induced severe
          chronic joint inflammation in rats. Our hypothesis is that peptidoglycan
          from the gut flora is involved in perpetuation of idiopathic inflammation.
          However, in the literature, the presence of peptidoglycan or subunits like
          muramyl peptides in blood or tissues is still a matter of debate. We were
          able to stain red pulp macrophages in all six available human spleens by
          immunohistochemical techniques using a monoclonal antibody against gut
          flora-derived antigens. Therefore, these human spleens were extracted, and
          after removal of most of the protein, the carbohydrate fraction was
          investigated for the presence of muramic acid, an amino sugar
          characteristic for peptidoglycan. Using three different methods for
          detection of muramic acid, we found a mean of 3.3 mumol of muramic acid
          with high-pressure liquid chromatography, 1.9 mumol with a colorimetric
          method for detection of lactate, and 0.8 mumol with an enzymatic method
          for detection of D-lactate per spleen (D-lactate is a specific group of
          the muramic acid molecule). It is concluded that peptidoglycan is present
          in human spleen not as small muramyl peptides as were previously searched
          for by other investigators but as larger macromolecules probably stored in
          spleen macrophages.</description>
    </item>
  </channel>
</rss>